• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬癌型胃癌的管理方案

Management protocol for scirrhous gastric cancer.

作者信息

Ikeguchi Masahide, Yamamoto Osamu, Kaibara Nobuaki

机构信息

Faculty of Medicine, Tottori University, Yonago 683-8504, Japan.

出版信息

In Vivo. 2004 Sep-Oct;18(5):577-80.

PMID:15523896
Abstract

BACKGROUND

The prognosis for patients with scirrhous gastric cancer (SGC) is extremely poor. However, the management protocol for this type of cancer has not been well discussed. In this study, we retrospectively evaluated the management of SGC and we introduced a new treatment protocol for SGC.

PATIENTS AND METHODS

Between 1991 and 2001, 58 patients with SGC were treated. Thirty-nine, who underwent gastrectomy, were divided into 3 sub-groups according to peritoneal metastasis (P) and peritoneal washing cytology (CY) status [P(-)/CY(-), P(-)/CY(+), and P(+)/CY(+)]. The survival rates of these 3 sub-groups were compared with patients who did not have a gastrectomy (n=19), retrospectively. From 2002, we started a new treatment protocol for SGC. Laparoscopic diagnosis of P or CY and intraperitoneal chemotherapy (IPC) were performed before performing laparotomy on 10 patients with SGC.

RESULTS

The 5-year survival rate of the 19 patients in P(-)/CY(-) was 11.6%. The survival rates of patients with P(-)/CY(+) or patients with P(+)/CY(+) were no different from patients who did not have gastrectomy (pleural effusion or ascites negative). In 10 patients who were treated with the new protocol, 7 with P(-)/CY(-) underwent gastrectomy after IPC and 3 with P(+)/CY(+) underwent repeated IPC.

CONCLUSION

Gastrectomy may not have prognostic benefit for patients with SGC with CY(+). Thus, we recommend laparoscopic diagnosis of peritoneal metastasis or peritoneal cytology before performing laparotomy on these patients.

摘要

背景

硬癌型胃癌(SGC)患者的预后极差。然而,针对这类癌症的治疗方案尚未得到充分讨论。在本研究中,我们回顾性评估了SGC的治疗情况,并引入了一种新的SGC治疗方案。

患者与方法

1991年至2001年间,58例SGC患者接受了治疗。39例行胃切除术的患者根据腹膜转移(P)和腹腔冲洗细胞学检查(CY)结果分为3个亚组[P(-)/CY(-)、P(-)/CY(+)和P(+)/CY(+)]。回顾性比较这3个亚组与未行胃切除术患者(n = 19)的生存率。从2002年起,我们开始了一种新的SGC治疗方案。对10例SGC患者在开腹手术前行腹腔镜检查以诊断P或CY并进行腹腔内化疗(IPC)。

结果

P(-)/CY(-)组的19例患者5年生存率为11.6%。P(-)/CY(+)组或P(+)/CY(+)组患者的生存率与未行胃切除术(胸腔积液或腹水阴性)的患者无差异。在采用新方案治疗的10例患者中,7例P(-)/CY(-)患者在IPC后行胃切除术,3例P(+)/CY(+)患者接受重复IPC。

结论

对于CY(+)的SGC患者,胃切除术可能对预后无益处。因此,我们建议在对这些患者进行开腹手术前,先进行腹腔镜检查以诊断腹膜转移或腹膜细胞学检查。

相似文献

1
Management protocol for scirrhous gastric cancer.硬癌型胃癌的管理方案
In Vivo. 2004 Sep-Oct;18(5):577-80.
2
Therapeutic strategy for scirrhous type gastric cancer.硬癌型胃癌的治疗策略
Hepatogastroenterology. 2005 Jan-Feb;52(61):314-8.
3
Prognostic value of peritoneal lavage cytology and chemotherapy during surgery for advanced gastric cancer.晚期胃癌手术中腹腔冲洗细胞学检查及化疗的预后价值
Int Surg. 1999 Jul-Sep;84(3):220-4.
4
Laparoscopic-assisted intraperitoneal chemotherapy for patients with scirrhous gastric cancer.腹腔镜辅助下腹腔内化疗治疗硬癌型胃癌患者
Chemotherapy. 2005 Mar;51(1):15-20. doi: 10.1159/000084018. Epub 2005 Feb 17.
5
Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.弥漫型进展期胃癌预后不佳,其特征为浸润更深且出现腹膜癌细胞:与肠型进展期胃癌的最新对比研究。
Hepatogastroenterology. 2009 Jan-Feb;56(89):276-81.
6
[Treatment strategy for the type IV gastric cancer--from the standpoint of the surgery].[IV型胃癌的治疗策略——从外科手术角度]
Gan To Kagaku Ryoho. 2007 Jul;34(7):983-7.
7
Survival of gastric cancer with concomitant liver metastases.伴有肝转移的胃癌的生存情况
Hepatogastroenterology. 2004 Sep-Oct;51(59):1527-30.
8
[Hyperthermia adjunct to surgery in the treatment of scirrhous carcinoma of the stomach].[热疗辅助手术治疗胃硬癌]
Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-2):1269-72.
9
Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach.胃硬癌患者的外科治疗结果
Am J Surg. 2004 Sep;188(3):327-32. doi: 10.1016/j.amjsurg.2004.06.010.
10
[Peritoneal dissemination of scirrhous type 4 gastric cancers].[4型硬癌性胃癌的腹膜播散]
Gan To Kagaku Ryoho. 2005 Oct;32(10):1384-8.

引用本文的文献

1
A novel semi-quantitative scoring method for CD8+ tumor-infiltrating lymphocytes based on infiltration sites in gastric cancer.一种基于胃癌浸润部位的CD8+肿瘤浸润淋巴细胞新型半定量评分方法。
Am J Cancer Res. 2024 Dec 25;14(12):5965-5986. doi: 10.62347/JKCU5881. eCollection 2024.
2
Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management.低黏附性细胞型胃癌,包括印戒细胞癌:定义、分类及治疗管理的最新综述
World J Gastrointest Oncol. 2022 Aug 15;14(8):1406-1428. doi: 10.4251/wjgo.v14.i8.1406.
3
The significance of a nineteenth century definition in the era of genomics: linitis plastica.
19世纪的一个定义在基因组学时代的意义:皮革胃。
World J Surg Oncol. 2017 Jul 5;15(1):123. doi: 10.1186/s12957-017-1187-3.
4
Type IV collagen levels are elevated in the serum of patients with peritoneal dissemination of gastric cancer.在胃癌腹膜播散患者的血清中,IV型胶原水平升高。
Oncol Lett. 2010 Nov;1(6):989-994. doi: 10.3892/ol.2010.181. Epub 2010 Sep 23.
5
Biological significance of localized Type IV scirrhous gastric cancer.局限性IV型硬化性胃癌的生物学意义
Oncol Lett. 2012 Jan;3(1):94-99. doi: 10.3892/ol.2011.454. Epub 2011 Oct 21.
6
RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility.RhoA/ROCK 信号转导介导硬癌型胃癌运动性的可塑性。
Clin Exp Metastasis. 2011 Oct;28(7):627-36. doi: 10.1007/s10585-011-9396-6. Epub 2011 Jun 12.
7
Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells.直接的癌-基质相互作用可增加成纤维细胞增殖,并增强硬癌型胃癌细胞的侵袭特性。
Br J Cancer. 2009 Oct 20;101(8):1365-73. doi: 10.1038/sj.bjc.6605309. Epub 2009 Sep 22.
8
Borrmann type IV: an independent prognostic factor for survival in gastric cancer.Borrmann Ⅳ型:胃癌生存的独立预后因素。
J Gastrointest Surg. 2008 Aug;12(8):1364-9. doi: 10.1007/s11605-008-0516-9. Epub 2008 May 31.